Goldman Sachs upgrades British American Tobacco stock rating on growth outlook
Goldman Sachs upgraded British American Tobacco (BTI) to Buy from Neutral, citing growth prospects in Velo and Vuse products, U.S. pouch market, and Asia Pacific recovery. The firm expects 4% organic sales growth by 2027-2028 and 6% EBIT growth over two years. BTI trades at a P/E of 15.9 and offers a 5.4% dividend yield.
How this was made
The 30-second read
Why it matters
The upgrade provides a clear catalyst for short‑term buying interest.
Market read
Analyst upgrade with specific growth drivers can move BTI's price and affect consumer‑staples sentiment.
What to watch
Potential headwinds from vaping regulations and competition in the nicotine‑pouch space.
Background
Goldman Sachs highlighted BTI's growth inflection points across multiple product lines and regions.
Ticker impact
Goldman Sachs upgraded British American Tobacco to Buy, citing growth from Velo, US pouch market, Vuse, and APAC recovery.
potential upside as investors price in higher organic sales and EBIT growth
Upgrade is a fresh, primary disclosure with specific growth thesis; market typically reacts positively to buy ratings.
Market effects
Tobacco sector may see renewed interest as growth narrative emerges.
Positive outlook for APAC and Middle East markets where BTI operates.
Upgrade could influence broader consumer staples sentiment.
Counterpoint
Skeptics may argue that regulatory risks and declining smoking rates outweigh growth from new products.
Key entities
- analystGoldman Sachs
Issued the upgrade and growth thesis.
- companyBritish American Tobacco
Subject of the upgrade.




